Welcome, Guest. Please login or register.
June 15, 2024, 03:10:27 pm

Login with username, password and session length

  • Total Members: 6309
  • Latest: Vicki
  • Total Posts: 55127
  • Total Topics: 4851
  • Online Today: 117
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 82
Total: 82


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Transplanting Kidneys From Donors With Hepatitis C Is Feasible  (Read 4860 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
People without hepatitis C virus who need a kidney transplant may be able to receive one from a donor with HCV and then promptly receive curative treatment for the virus, Reuters Health reports. A recent small study found that direct-acting antiviral treatment was successful in this context and was not associated with any major treatment-related negative safety outcomes.

Publishing their findings in the Annals of Internal Medicine, researchers studied 10 HCV-negative individuals on the kidney transplant list. They had a median age of 71, 20 percent were women and 80 percent were white. They each received one transplanted kidney from 10 donors. The donors had a median age of 30, 50 percent were women and all were white. The organ recipients waited for a median of one month between entering the study and receiving a kidney transplant.



© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.